NextGen Healthcare, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXGN research report →
About the company
NextGen Healthcare, Inc. stands as a leading provider of healthcare technology solutions across the United States. The company's extensive portfolio addresses critical clinical, financial, and administrative needs, offering products such as NextGen Enterprise EHR for electronic health records, NextGen Enterprise PM for practice management, and NextGen Virtual Visits to facilitate patient engagement.
- CEO
- David William Sides
- IPO
- 1982
- Employees
- 2,783
- HQ
- Atlanta, GA, US
Price Chart
- Market Cap
- $1.61B
- P/E
- -598.50
- P/S
- 2.46
- P/B
- 3.97
- EV/EBITDA
- 37.10
- Div Yield
- 0.00%
- Gross Margin
- 47.64%
- Op Margin
- 2.49%
- Net Margin
- -0.41%
- ROE
- -0.64%
- ROIC
- -1.43%
- Revenue
- $653.17M · 9.53%
- Net Income
- $-2,654,000 · -264.03%
- EPS
- $-0.04 · -300.00%
- Op Income
- $16.24M
- FCF YoY
- -74.88%
- 52W High
- $23.98
- 52W Low
- $15.23
- 50D MA
- $23.28
- 200D MA
- $18.60
- Beta
- 0.77
- Avg Volume
- 1.26M
Get TickerSpark's AI analysis on NXGN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 9, 23 | Barbarosh Craig A. | sell | 9,483 |
| Nov 9, 23 | Barbarosh Craig A. | sell | 67,269 |
| Nov 9, 23 | Sides David William | sell | 605,540 |
| Nov 9, 23 | Sides David William | sell | 381,059 |
| Nov 9, 23 | Ahmadzai David | sell | 14,315 |
| Nov 9, 23 | Ahmadzai David | sell | 3,000 |
| Nov 9, 23 | Ahmadzai David | sell | 44,555 |
| Nov 7, 23 | Sides David William | other | 6,500 |
| Nov 9, 23 | Dent Darnell | sell | 31,028 |
| Nov 9, 23 | Bristol George H | sell | 82,889 |
Our NXGN coverage
Recent articles, reports, and earnings notes.
No research on NXGN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NXGN report →Similar companies
Peers in the same neighborhood.